验证码已发送至您的邮箱或手机,请查收。
HIV DNA vaccine (FIT Biotech/IAVI)
(GTU MultiHIV®) Phase II Active
A vaccine potentially for the prevention and treatment of HIV infection.
Research Code FIT-06
CAS No.
Recombinant acellular pertussis vaccine (BioNet-Asia)
(Viaskin rPT, Viaskin-PT ®) Approved
A recombinant acellular pertussis vaccine used to prevent of pertussis.
Research Code
CAS No.
Anti-MUC1 monoclonal antibody (OncoQuest)
(BrevaRex®) Phase II Active
A mucin 1 (MUC1) targeted antibody potentially for the treatment for pancreatic cancer.
Research Code Anti-MUC1 AR20.5; AR20.5; mAb-AR20.5
CAS No.
(HibTITER®) Withdrawn
A Haemophilus influenzae type B (Hib) and CRM197 conjugate vaccine usd to prevent Hib infection.
Research Code MT-2301; NU-300
CAS No.
Research Code IL-12p70 DC vaccine
CAS No.
Research Code QR-333
CAS No.
Research Code ICX-PRO; ICXP-007
CAS No.
(StaphTAME®) Phase II Active
A recombinant protein potentially for the treatment of staphylococcal infection.
Research Code P-128
CAS No.
Phase II Discontinued
A protein synthesis inhibitor potentially for the treatment of corneal ulcer and dry eyes.
Research Code CBS-211A
CAS No.
101506-83-6(Namirotene)
Phase III Discontinued
Research Code CBS-113A
CAS No.
110952-54-0(CBS-113A)
138511-81-6(Icoduline)
NDA Filing Pending
A cyclooxygenase (COX) inhibitor potentially for the treatment of rheumatic disorders.
Research Code BA-760506; PV-102
CAS No.
67489-39-8(Talmetacin)
Cal 1-transduced haematopoietic stem progenitor cell
Phase II Active
A gene therapy potentially for the treatment of HIV infection.
Research Code CAL-1; CAL-MGMT; LVsh5C46; VIP
CAS No.
Phase I Active
A plant derived recombinant protective antigen vaccine potentially for the prevention of anthrax.
Research Code PA-83-FhCMB; PA83-FhCMB
CAS No.
Influenza A virus vaccine H5N1 (iBio)
Phase I Active
A vaccine for the prevention of influenza A virus H5N1 infection.
Research Code
CAS No.
Phase II Active
Research Code KB-004
CAS No.
Phase II Discontinued
Research Code KB-001; KB-001A
CAS No.
Phase II Active
Research Code KB-003
CAS No.
1229575-09-0
Phase I Active
A DNA vaccine potentially for the prevention of middle-east respiratory syndrome virus infection.
Research Code GLS-5300
CAS No.
Phase I Active
Research Code VGX-3400; VGX-3400X
CAS No.
Recombinant acellular pertussis vaccine (BioNet-Asia)
A recombinant acellular pertussis vaccine used to prevent of pertussis.
A recombinant protein potentially for the treatment of staphylococcal infection.
Successful modification
Please choose to cancel the drug